| 1 |
Platzbecker, Uwe; Della Porta, Matteo Giovanni; Santini, Valeria; Zeidan, Amer M; Komrokji, Rami S; Shortt, Jake; Valcarcel, David; Jonasova, Anna; Dimicoli-Salazar, Sophie; Tiong, Ing Soo; Lin, Chien-Chin; Li, Jiahui; Zhang, Jennie; Giuseppi, Ana Carolina; Kreitz, Sandra; Pozharskaya, Veronika; Keeperman, Karen L; Rose, Shelonitda; Shetty, Jeevan K; Hayati, Sheida; Vodala, Sadanand; Prebet, Thomas; Degulys, Andrius; Paolini, Stefania; Cluzeau, Thomas; Fenaux, Pierre; Garcia-Manero, Guillermo. Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial // The Lancet. New York : Elsevier. ISSN 0140-6736. eISSN 1474-547X. 2023, vol. 402, iss. 10399, p. 373-385. DOI: 10.1016/S0140-6736(23)00874-7. [DB: Science Citation Index Expanded (Web of Science), Scopus] |
| 2 |
Garcia-Manero, Guillermo; Platzbecker, Uwe; Santini, Valeria; Zeidan, Amer M.; Fenaux, Pierre; Komrokji, Rami S.; Shortt, Jake; Valcarcel, David; Jonasova, Anna; Dimicoli-Salazar, Sophie; Tiong, Ing Soo; Lin, Chien-Chin; Li, Jiahui; Zhang, Jennie; Giuseppi, Ana Carolina; Kreitz, Sandra; Pozharskaya, Veronika; Keeperman, Karen L.; Rose, Shelonitda; Prebet, Thomas; Degulys, Andrius; Paolini, Stefania; Cluzeau, Thomas; Della Porta, Matteo Giovanni. Efficacy and safety of luspatercept versus epoetin alfa in Erythropoiesis-Stimulating Agent (ESA)-naive patients (Pts) with Transfusion-Dependent (TD) Lower-Risk Myelodysplastic Syndromes (LR-MDS): full analysis of the COMMANDS trial // Blood: 65th annual meeting of the American-Society-of-Hematology (ASH), San Diego, CA, December 09-12, 2023. Washington : American Society of Hematology. ISSN 0006-4971. eISSN 1528-0020. 2023, vol. 142, suppl. 1, p. 193. DOI: 10.1182/blood-2023-178596. [DB: Science Citation Index Expanded (Web of Science)] |
| 3 |
Platzbecker, U.; Della Porta, M. G.; Santini, V.; Zeidan, A. M.; Fenaux, P.; Komrokji, R. S.; Shortt, J.; Valcarcel, D.; Jonasova, A.; Dimicoli-Salazar, S.; Tiong, I. S.; Lin, C. -C.; Li, J.; Zhang, J.; Giuseppi, A. C.; Kreitz, S.; Pozharskaya, V.; Keeperman, K. L.; Rose, S.; Shetty, J. K.; Hayati, S.; Vodala, S.; Degulys, Andrius; Paolini, S.; Cluzeau, T.; Garcia-Manero, G. Luspatercept Versus Epoetin Alfa for Treatment (Tx) of Anemia in Erythropoiesis-Stimulating Agent (ESA)-Naive Lower-Risk Myelodysplastic Syndromes (LR-MDS) Patients (pts) Requiring RBC Transfusions (RBCT): Data from the Phase 3 COMMANDS Study // Oncology research and treatment: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 13. bis 16. Oktober 2023, Hamburg: Abstracts: DGHO abstracts. Basel : Karger. ISSN 2296-5270. eISSN 2296-5262. 2023, vol. 46, suppl. 5, p. 16-17. DOI: 10.1159/000533576. [DB: Science Citation Index Expanded (Web of Science)] |